Medicare Enrolled

Dr. John Tyler, M.D.

Cardiovascular Disease · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6655 TRAVIS ST STE 500, Houston, TX 77030
7135787648
In practice since 2012 (13 years)
NPI: 1275890329 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tyler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tyler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tyler

Dr. John Tyler is a cardiovascular disease in Houston, TX, with 13 years in practice. Based on federal Medicare data, Dr. Tyler performed 3,981 Medicare services across 1,188 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tyler received a total of $10,208 from 44 pharmaceutical and/or device companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tyler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 25% volume in TX$ $10,208 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,981
Medicare services
Top 25% in TX for cardiovascular disease
1,188
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~306 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)2,335$0$4
Office visit, established patient (30-39 min)481$89$220
Electrocardiogram (EKG), 12-lead222$11$67
Regadenoson injection (Lexiscan) for heart stress test208$44$78
Echocardiogram, transthoracic136$152$720
Heart muscle strain imaging108$30$150
New patient office visit (45-59 min)72$114$336
EKG interpretation and report61$5$18
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes60$9$14
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries53$602$1,443
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician52$52$420
Nuclear medicine studies of blood flow in heart muscle at rest and with stress51$1,059$3,220
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes31$41$64
Ultrasonic guidance for blood vessel access26$21$250
Initial hospital admission, high complexity24$134$417
Hospital follow-up visit, moderate complexity21$61$149
Heart rhythm recording of continous external ekg over 8-15 days14$10$55
Heart rhythm review and interpretation of continous external ekg over 8-15 days14$21$80
Cardiac catheterization12$590$14,200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.7% high complexity
69.2% medium
27.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,208
Total received (2018-2024)
Avg $1,458/year across 7 years
Top 31% in TX for cardiovascular disease
44
Companies
430
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,208 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$698
2023
$1,235
2022
$1,497
2021
$1,082
2020
$1,349
2019
$1,890
2018
$2,457

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,221
Edwards Lifesciences Corporation
$1,109
Amgen Inc.
$909
PFIZER INC.
$887
Novartis Pharmaceuticals Corporation
$713
E.R. Squibb & Sons, L.L.C.
$536
SANOFI-AVENTIS U.S. LLC
$495
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$430
Amarin Pharma Inc.
$359
Medtronic Vascular, Inc.
$308
Novo Nordisk Inc
$299
AstraZeneca Pharmaceuticals LP
$268
Kowa Pharmaceuticals America, Inc.
$243
Gilead Sciences, Inc.
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Astellas Pharma US Inc
$195
Esperion Therapeutics, Inc.
$192
Abbott Laboratories
$182
Regeneron Healthcare Solutions, Inc.
$164
Akcea Therapeutics, Inc.
$162
Preventice Services, LLC
$131
Actelion Pharmaceuticals US, Inc.
$116
Merck Sharp & Dohme LLC
$113
Philips Electronics North America Corporation
$104
iRhythm Technologies, Inc.
$70
Impulse Dynamics (USA) Inc.
$64
CARDIVA MEDICAL, INC.
$60
ARBOR PHARMACEUTICALS, INC.
$58
BOSTON SCIENTIFIC CORPORATION
$54
SCPHARMACEUTICALS INC.
$43
Bayer HealthCare Pharmaceuticals Inc.
$42
Relypsa, Inc.
$40
Tactile Systems Technology Inc
$30
Lexicon Pharmaceuticals, Inc.
$23
Boston Scientific Corporation
$21
Inari Medical, Inc.
$19
ARALEZ PHARMACEUTICALS US INC.
$19
W. L. Gore & Associates, Inc.
$19
Lantheus Medical Imaging, Inc.
$17
Chiesi USA, Inc.
$17
AGEPHA Pharma FZ LLC
$15
Arbor Pharmaceuticals, Inc.
$13
Vifor Pharma, Inc.
$13
Bardy Diagnostics, Inc.
$12
Top 3 companies account for 31.7% of total payments
Associated products mentioned in payments ›
Advisa · Allure Quadra RF CRT Pacemaker · BRILINTA · CAMZYOS · CHANTIX · Carnation Ambulatory Monitor · CoreValve Evolut · Corlanor · DISEASE STATE · Definity · ELIQUIS · ENTRESTO · Edarbi · Evekeo · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GORE CARDIOFORM Septal Occluder · Horizant · IGT_D Peripheral · INVOKANA · Image Guided Therapy Devices _ Peripheral · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LIVALO · LODOCO · LifeVest · Livalo · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · OPSUMIT · OPTIMIZER · OPTOWIRE · Optimizer · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Repatha · S · TEGSEDI · Trilogy 100 · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · Verquvo · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $256 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tyler is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tyler experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Tyler performed 2,335 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tyler receive payments from pharmaceutical companies?
Yes. Dr. Tyler received a total of $10,208 from 44 companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tyler's costs compare to other cardiovascular diseases in Houston?
Dr. Tyler's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tyler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →